Last reviewed · How we verify
Blood-stage infection of P. vivax
Blood-stage infection of P. vivax is a Biologic drug developed by State Key Laboratory of Respiratory Disease. It is currently in Phase 1 development.
At a glance
| Generic name | Blood-stage infection of P. vivax |
|---|---|
| Sponsor | State Key Laboratory of Respiratory Disease |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays (PHASE1)
- Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia (PHASE2)
- A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes (NA)
- Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield (NA)
- VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection (EARLY_PHASE1)
- Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure (PHASE4)
- Plasmodium Immunotherapy for Advanced Cancers (PHASE1, PHASE2)
- Plasmodium Immunotherapy for Advanced Malignant Solid Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood-stage infection of P. vivax CI brief — competitive landscape report
- Blood-stage infection of P. vivax updates RSS · CI watch RSS
- State Key Laboratory of Respiratory Disease portfolio CI
Frequently asked questions about Blood-stage infection of P. vivax
What is Blood-stage infection of P. vivax?
Blood-stage infection of P. vivax is a Biologic drug developed by State Key Laboratory of Respiratory Disease.
Who makes Blood-stage infection of P. vivax?
Blood-stage infection of P. vivax is developed by State Key Laboratory of Respiratory Disease (see full State Key Laboratory of Respiratory Disease pipeline at /company/state-key-laboratory-of-respiratory-disease).
What development phase is Blood-stage infection of P. vivax in?
Blood-stage infection of P. vivax is in Phase 1.